Next Article in Journal
The Prognostic and Predictive Significance of Tumor-Infiltrating Memory T Cells Is Reversed in High-Risk HNSCC
Next Article in Special Issue
Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives
Previous Article in Journal
Telomere Maintenance and the cGAS-STING Pathway in Cancer
Previous Article in Special Issue
Immunomodulatory Effects Associated with Cladribine Treatment
 
 

Order Article Reprints

Journal: Cells, 2022
Volume: 11
Number: 1959

Article: Ocrelizumab in Patients with Active Primary Progressive Multiple Sclerosis: Clinical Outcomes and Immune Markers of Treatment Response
Authors: by Marina Boziki, Christos Bakirtzis, Styliani-Aggeliki Sintila, Evangelia Kesidou, Evdoxia Gounari, Aliki Ioakimidou, Vasiliki Tsavdaridou, Lemonia Skoura, Asimina Fylaktou, Vasiliki Nikolaidou, Maria Stangou, Ioannis Nikolaidis, Virginia Giantzi, Eleni Karafoulidou, Paschalis Theotokis and Nikolaos Grigoriadis
Link: https://www.mdpi.com/2073-4409/11/12/1959

MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article and designed to be complimentary to the journal.

Order Cost and Details

Shipping Address

Billing Address

Notes or Comments

Validate and Place Order

The order must be prepaid after it is placed

req denotes required fields.
Back to TopTop